JB Chemicals & Pharmaceuticals Ltd.

The total asset value of JB Chemicals & Pharmaceuticals Ltd. stood at ₹ 3,799 Cr as on 30-Sep-23

The share price of JB Chemicals & Pharmaceuticals Ltd. is ₹1,460.45 (NSE) and ₹1,459.20 (BSE) as of 01-Dec-2023 IST. JB Chemicals & Pharmaceuticals Ltd. has given a return of 43.2% in the last 3 years.

JB Chemicals & Pharmaceuticals Ltd. has a market capitalisation of ₹ 22,624 Cr as on 01-Dec-2023. As per Value Research classification, it is a Mid Cap company.

The P/B ratio of JB Chemicals & Pharmaceuticals Ltd. is 8.33 times as on 01-Dec-2023, a 1.54% premium to its peers’ median range of 3.28 times.

The P/E ratio of JB Chemicals & Pharmaceuticals Ltd. is 46.49 times as on 01-Dec-2023, a 0.55% premium to its peers’ median range of 30.01 times.

Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the JB Chemicals & Pharmaceuticals Ltd. and enter the required number of quantities and click on buy to purchase the shares of JB Chemicals & Pharmaceuticals Ltd..

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, dimethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides contract manufacturing services for tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners. The company provides its services in gastroenterology, anti-infectives, wound care, neonatology and pediatrics, gynecology, dental, vitamins and minerals, hypertension, diabetes, nephrology, respiratory, pain-analgesic, dermatology, antivirals, lozenges, and contrast media and radio diagnostic therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Mumbai, India.

The promoter of JB Chemicals & Pharmaceuticals Ltd. is TAU INVESTMENT HOLDINGS PTE. LTD.. TAU INVESTMENT HOLDINGS PTE. LTD. owns 53.86 per cent of the total equity. The chairman of the company is Ranjit Shahani ..

The promoters of JB Chemicals & Pharmaceuticals Ltd. have pledged 0% of the total equity as on Sep-23.

Some of the close peers are:

Yes, TTM profit after tax of JB Chemicals & Pharmaceuticals Ltd. was ₹487 Cr.